Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.50
Bid: 219.00
Ask: 220.00
Change: 5.50 (2.56%)
Spread: 1.00 (0.457%)
Open: 216.50
High: 220.50
Low: 216.00
Prev. Close: 215.00
TCAP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

1 Nov 2022 07:00

RNS Number : 8199E
TP ICAP Group PLC
01 November 2022
 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

LEI: 2138006YAA7IRVKKGE63

 

1 November 2022

 

Trading update for the nine months ended 30 September 2022

 

 

Year-to-date performance (in constant currency, unless in brackets, which denotes reported currency)

 

Revenue

 

Total Group revenue of £1,588m in the first nine months of 2022 was up 10% (+15% in reported currency), compared with the same period in 2021. The Group benefitted from favourable market conditions in Global Broking, particularly in Rates, our largest, and most profitable, asset class. The ongoing strengthening of the US Dollar has been a meaningful tailwind: approximately 60% of the Group's revenue (and approximately 40% of costs) are US Dollar denominated. Excluding Liquidnet (completed on 23 March 2021), revenue increased by 7% (+12%).

 

At the divisional level, Global Broking revenue was up 9% (+14%). All asset classes generated high single digit to double digit growth. This performance underlines the strength of the franchise, which is well positioned as Central Banks continue to withdraw liquidity and increase interest rates.

 

In Energy & Commodities (E&C), revenue declined by 3% (+3%), in line with exchange volumes. Oil, our largest asset class in E&C, delivered low single digit growth. As previously reported, the European Gas & Power market is challenging: significant price rises and increased exchange margin requirements resulted in liquidity contracting and low levels of market activity.

 

Agency Execution revenue, including Liquidnet, was up 34% (+40%). Liquidnet revenue, on a proforma basis, declined by 9% (-7%). In Europe, there was a decline in larger block market trading activity. In the US, there was a shift in mix towards lower rate client segments. Liquidnet's market share in the US and Europe was broadly unchanged. Parameta Solutions revenue grew by 6% (+15%), with Data & Analytics (D&A) up 9% (+18%).

 

The Group, as a whole, continues to trade in line with the Board's expectations.

 

Third quarter performance (in constant currency, unless in brackets, which denotes reported currency)

 

During the third quarter of 2022, total Group revenue was £508m, up 5% (+14%) compared with the same period in 2021.

 

Global Broking revenue was up 12% (+20%). All asset classes generated high single digit to double digit growth, reflecting the continued strong performance. E&C revenue declined by 12% (-3%). In Agency Execution, including Liquidnet, revenue declined by 1% (+6%). Liquidnet revenue declined by 22% (-18%), reflecting the market conditions noted above. In addition, US Agency Alternative Trading System (ATS) volumes, a key contributor for Liquidnet, were subdued, compared with exchanges and OTC venues. Parameta Solutions revenue grew by 6% (+22%), while D&A revenue was up 7% (+24%).

 

2022 preliminary results

 

The Group will report its 2022 preliminary results on 14 March 2023. At the results, the Agency Execution division will be reported on a consolidated basis as Liquidnet.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries:

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFEIIILLVIF
Date   Source Headline
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20243:00 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 202411:00 amRNS2023 Annual Report and Notice of 2024 AGM
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202411:00 amRNSHolding(s) in Company
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20244:45 pmRNSDirector/PDMR Shareholding
4th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:45 pmRNSBlock Listing Application
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:01 amRNSLaunch of second share buyback programme of £30m
12th Mar 20247:00 amRNSFinal Results
31st Jan 20241:00 pmRNSHolding(s) in Company
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.